Antianginal agents Flashcards
treatment strategies
- decrease O2 demand
2. increase O2 delivery
nitrates MOA
releases NO when metabolized → binds to and activates guanylyl cyclase, leading to ↑ cGMP
antiischemic effect of nitrates
decrease myocardial O2 demand by producing systemic vasodilation.
How do nitrates decrease platelet aggregation?
NO stimulation of guanylate cyclase in platelets results in increased platelet cGMP
nitrate tolerance
• Effectiveness diminishes significantly with continuous use
• A nitrate-free period of at least 8 hours between doses is required to prevent tolerance
o Generally not a problem with sublingual nitroglycerin
nitrate drug/drug interaction
• Synergistic hypotension wth phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) because they both act by increasing GMP
First line therapy to reduce frequency of angina and improve exercise tolerance
Propanolol
Why are beta blockers not effective in variant angina
Variant angina is due to vasospasm which is mediated by alpha 1. Beta blockers work on beta receptors
beta blockers could precipitate the problem!
beta blocker contraindications
• Asthma/COPD
o Blockade of β2 receptors in bronchial smooth muscle may lead to increase in airway resistance
• Diabetes
o Glycogenolysis is partially inhibited after β2 blockade
o May mask signs of hypoglycemia
clinical use of beta blockers
ischemic heart diseae
stabilizes heart rate and prolongs survival after MI
timolol, propanolol, metropolol
propanolol drug/drug interaction
Can cause heart block if combined with a CCB (verapamil or diltiazem) → will slow conduction
DHP pharmocodynamics
- Arterioles more sensitive than veins
- Orthostatic hypotension is not a problem.
- Relaxation of arteriolar smooth muscle leads to decreased afterload and decreased O2 demand
- Little effect on preload
- Also increases O2 supply due to dilation of coronaries
Adverse effects of verapamil
constipation
peripheral edema
Contraindications for CCBs
- Use of verapamil/dilitiazem with a β-blocker is contraindicated because of the potential for AV block
- Should not be used in pts with ventricular dysfunction, SA or AV nodal conduction defects
- Short-acting DHPs can cause reflex tachycardia
MOA of ranolazine
ate Na channel blocker that facilitates Ca entry; resultant reduction in intracellular calcium reduces cardiac contractility and work